Effect of Vitamin D supplementation on immune response following COVID vaccine
Phase 3
- Registration Number
- CTRI/2021/08/035709
- Lead Sponsor
- SEHEAC New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
a)Adults enrolling for the 1st dose of COVISHIELD vaccine and consenting to participate
b)Age between 18 to 60 years
Exclusion Criteria
a)Pregnancy/Lactation
b)Those on chronic glucocorticoid therapy ( >5mg/d in prior 3 months)
c)HIV or other known immunodeficiency
d)CKD/ESRD
e)25(OH)D >30ng/ml at baseline
f)IgG to spike protein >800mU/ml
g)Malignancy/ Lymphoma
h)Psychiatric illness
i)Other immunosuppressive treatment
j)Hypercalcemia ( >10.2mg/dl)
k)Not consenting
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method